|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Pathophysiology/Complications |
Do Sensor Glucose Levels Accurately Predict Plasma Glucose Concentrations During Hypoglycemia and Hyperinsulinemia?
1 Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut
2 Pediatric Pharmacology Research Unit, Yale University School of Medicine, New Haven, Connecticut
3 Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
4 General Clinical Research Centers, Yale University School of Medicine, New Haven, Connecticut
OBJECTIVE—The MiniMed Continuous Glucose Monitoring System (CGMS) measures subcutaneous interstitial glucose levels that are calibrated against three or more fingerstick glucose levels daily. The objective of the present study was to examine whether the relationship between plasma and interstitial fluid glucose is altered by changes in plasma glucose and insulin levels and how such alterations might influence CGMS performance.
RESEARCH DESIGN AND METHODS—Arterialized plasma glucose, sensor glucose, and interstitial fluid glucose were measured by microdialysis in 11 healthy subjects during a 1.0 mU · kg-1 · min-1 stepped euglycemic-hypoglycemic-hyperglycemic (plasma glucose 
5, 3.1, and 8.6 mmol/l, respectively) insulin clamp that raised plasma insulin to 360–390 pmol/l.
RESULTS—When the CGMS was calibrated versus plasma glucose levels before insulin infusion, basal sensor and plasma glucose were similar (5.0 ± 0.3 vs. 5.2 ± 0.3 mmol/l, respectively); dialysate glucose was 3.3 ± 0.9 mmol/l. During the hyperinsulinemic-euglycemia study (plasma glucose 4.9 ± 0.3 mmol/l), dialysate glucose fell by 30–35%, accompanied by a significant reduction in sensor glucose (to 3.7 ± 0.6 mmol/l; P < 0.001 vs. plasma). Subsequently, sensor levels remained lower than plasma values during mild hypoglycemia (2.5 ± 0.6 vs. 3.1 ± 0.3 mmol/l; P < 0.01) and during recovery from hypoglycemia (7.3 ± 1.2 vs. 8.6 ± 0.6; P < 0.01). However, when the CGMS was calibrated against plasma glucose levels before and during each step of the clamp, sensor glucose levels increased throughout the study and did not differ from plasma glucose values during hypoglycemia.
CONCLUSIONS—Although hyperinsulinemia may contribute to modest discrepancies between plasma and sensor glucose levels, the CGMS is able to accurately track acute changes in plasma glucose when calibrated across a range of plasma glucose and insulin levels.
Abbreviations: ECF, extracellular fluid • CGMS, Continuous Glucose Monitoring System
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  P. G. McNally, J. D. Dean, A. D. Morris, P. D. Wilkinson, G. Compion, and S. R. Heller Using Continuous Glucose Monitoring to Measure the Frequency of Low Glucose Values When Using Biphasic Insulin Aspart 30 Compared With Biphasic Human Insulin 30: A double-blind crossover study in individuals with type 2 diabetes Diabetes Care, May 1, 2007; 30(5): 1044 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Allport, T. Baird, K. Butcher, L. MacGregor, J. Prosser, P. Colman, and S. Davis Frequency and Temporal Profile of Poststroke Hyperglycemia Using Continuous Glucose Monitoring Diabetes Care, August 1, 2006; 29(8): 1839 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ellmerer, M. Haluzik, J. Blaha, J. Kremen, S. Svacina, W. Toller, J. Mader, L. Schaupp, J. Plank, and T. Pieber Clinical Evaluation of Alternative-Site Glucose Measurements in Patients After Major Cardiac Surgery. Diabetes Care, June 1, 2006; 29(6): 1275 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Monnier, E. Mas, C. Ginet, F. Michel, L. Villon, J.-P. Cristol, and C. Colette Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes JAMA, April 12, 2006; 295(14): 1681 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Wentholt, M. A. Vollebregt, A. A. Hart, J. B. Hoekstra, and J. H. DeVries Comparison of a Needle-Type and a Microdialysis Continuous Glucose Monitor in Type 1 Diabetic Patients Diabetes Care, December 1, 2005; 28(12): 2871 - 2876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sapountzi, G. Charnogursky, M. A. Emanuele, D. Murphy, F. Nabhan, and N. V. Emanuele Case Study: Diagnosis of Insulinoma Using Continuous Glucose Monitoring System in a Patient With Diabetes Clin. Diabetes, July 1, 2005; 23(3): 140 - 143. [Full Text] [PDF]
|
|
|
|
|
|
T. Richardson, P. Thomas, J. Ryder, and D. Kerr Influence of Caffeine on Frequency of Hypoglycemia Detected by Continuous Interstitial Glucose Monitoring System in Patients With Long-Standing Type 1 Diabetes Diabetes Care, June 1, 2005; 28(6): 1316 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Babu, J. Herdegen, L. Fogelfeld, S. Shott, and T. Mazzone Type 2 Diabetes, Glycemic Control, and Continuous Positive Airway Pressure in Obstructive Sleep Apnea Arch Intern Med, February 28, 2005; 165(4): 447 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Weintrob, A. Schechter, H. Benzaquen, S. Shalitin, P. Lilos, A. Galatzer, and M. Phillip Glycemic Patterns Detected by Continuous Subcutaneous Glucose Sensing in Children and Adolescents With Type 1 Diabetes Mellitus Treated by Multiple Daily Injections vs Continuous Subcutaneous Insulin Infusion Arch Pediatr Adolesc Med, July 1, 2004; 158(7): 677 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Regittnig, M. Ellmerer, G. Fauler, G. Sendlhofer, Z. Trajanoski, H.-J. Leis, L. Schaupp, P. Wach, and T. R. Pieber Assessment of transcapillary glucose exchange in human skeletal muscle and adipose tissue Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E241 - E251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Desouza, H. Salazar, B. Cheong, J. Murgo, and V. Fonseca Association of Hypoglycemia and Cardiac Ischemia: A study based on continuous monitoring Diabetes Care, May 1, 2003; 26(5): 1485 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chico, P. Vidal-Rios, M. Subira, and A. Novials The Continuous Glucose Monitoring System Is Useful for Detecting Unrecognized Hypoglycemias in Patients With Type 1 and Type 2 Diabetes but Is Not Better Than Frequent Capillary Glucose Measurements for Improving Metabolic Control Diabetes Care, April 1, 2003; 26(4): 1153 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Guerci, M. Floriot, P. Bohme, D. Durain, M. Benichou, S. Jellimann, and P. Drouin Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs Diabetes Care, March 1, 2003; 26(3): 582 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Monnier, H. Lapinski, and C. Colette Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients: Variations with increasing levels of HbA1c Diabetes Care, March 1, 2003; 26(3): 881 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Flanagan, M. L. Evans, T. P. Monsod, F. Rife, R. A. Heptulla, W. V. Tamborlane, and R. S. Sherwin The influence of insulin on circulating ghrelin Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E313 - E316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Choleau, P. Dokladal, J.-C. Klein, W. K. Ward, G. S. Wilson, and G. Reach Prevention of Hypoglycemia Using Risk Assessment With a Continuous Glucose Monitoring System Diabetes, November 1, 2002; 51(11): 3263 - 3273. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |